BioCardia, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • April 12th, 2022 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 12th, 2022 Company Industry JurisdictionBioCardia, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: